Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
Alemtuzumab Therapy for Multiple Sclerosis.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
The role of regulatory T cells in neurodegenerative diseases.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Fingolimod (Gilenya) licence extended
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.

Pages